This content is from: Direct Tax
Deals of the week - April 9 2012
| TYPE OF DEAL | VALUE | ACQUIRER | TARGET | ADVISER TO ACQUIRER (TAX) | ADVISER TO TARGET (TAX) |
| Merger | $1.4 billion | Justice Holdings / Pershing Square Capital | Burger King Worldwide | Sullivan & Cromwell - Davis Wang / Greenberg Traurig | Kirkland & Ellis |
| Patent Deal | $1.1 billion | Microsoft | AOL | Covington & Burling | Wachtell, Lipton, Rosen & Katz / Finnegan, Henderson, Farabow, Garrett & Dunner |
| Acquisition | $1 billion | Fenwick & West - Adam Halpern, Natalie Pardo de Zela | Orrick | ||
| Acquisition | $950 million | Cerberus Capital | AT&T (Yellow Pages) | Schulte Roth - Alan Waldenberg | Sullivan & Cromwell - Andrew Mason |
| Acquisition | $221.4 million | Witwatersrand Consolidated Gold Resources / Pan African Resources | Evander Gold Mines (Harmony Gold Mining) | Stikeman Elliott / Eversheds | |
| TYPE OF DEAL | VALUE | ISSUER / BORROWER | LEAD MANAGERS / ARRANGERS | ADVISER TO ISSUER / BORROWER | ADVISER TO LEAD MANAGERS |
| Notes Offering | $3 billion | Apache | Citigroup / Goldman Sachs / J.P. Morgan | Bracewell & Giuliani | Davis Polk & Wardwell - Michael Farber, Juelle Gomes |
| Notes Offering | $2.15 billion | Hartford Financial | Citigroup / Goldman Sachs | Davis Polk & Wardwell - Harry Ballan, Yuliya Epifantseva | Cleary Gottlieb Steen & Hamilton |
| Senior Notes Offering | $1.5 billion | Lloyds TSB | Citigroup / Merrill Lynch / Morgan Stanley / Wells Fargo | Linklaters / Dundas & Wilson / Davis Polk & Wardwell | Allen & Overy |
| Refinancing | $1.25 billion | Cargill | ANZ / Tokyo-Mitsubishi UFJ / BNP Paribas / Deutsche Bank / HSBC / RBS / Standard Chartered | WongPartnership | Linklaters |
| High-yield Notes Offering | $1.1 billion | OGX | Davis Polk & Wardwell - Po Sit, Ankur Dalal | White & Case / Machado Meyer Sendacz Opice | |
| Initial Public Offering | $490 million | Rexnord | Merrill Lynch / Goldman Sachs / Credit Suisse / Deutsche Bank / Barclays | O’Melveny & Myers | Davis Polk & Wardwell - Samuel Dimon, Arie Rubenstein |
| Initial Public Offering | $100.1 million | Merrimack Pharmaceuticals | JP Morgan | Wilmer Cutler Pickering Hale and Dorr | Davis Polk & Wardwell - Neil Barr, Changsheng Song |
The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms and Conditions and Privacy Policy before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQ.